Hiliks Technologies completed a preferential allotment of 23 lakh equity shares and 11.5 lakh convertible warrants on September 19, 2026. The company raised ₹16.56 crore from the immediate equity issuance, with a total potential consideration of ₹24.84 crore including the warrants.

The Board of Directors approved the allotment pursuant to a shareholder resolution dated August 1, 2026, and in-principle approvals from BSE Limited and Metropolitan Stock Exchange of India Ltd. (MSEI) received on September 4, 2026. The securities were issued at a price of ₹72 per share or warrant, comprising a face value of ₹10 and a premium of ₹62.

Equity Share Allotment

The company allotted 23 lakh equity shares to five non-promoter investors. Qualified Institutional Buyers (QIBs) accounted for the majority of the equity stake.

Post-allotment, Aegis Investment Fund PCC holds a 9.15% stake, while Niveza Small Cap Fund holds 4.93%. The other three allottees each hold a 0.70% stake on a fully diluted basis.

Convertible Warrants

The company also allotted 11.5 lakh convertible warrants to four non-promoter investors. Each warrant is convertible into one fully paid-up equity share. Investors paid 25% of the issue price upfront, with the remaining 75% payable upon conversion.

Enact Technologies Private Limited emerged as the largest warrant holder. Post-allotment, its stake increases from 19.65% to 20.49% on a fully diluted basis. The warrants can be converted into equity shares within 18 months of allotment, in one or more tranches.

What the Numbers Show

The capital raise demonstrates distinct investor segmentation: institutional investors focused on immediate equity exposure, while corporate and individual investors opted for leveraged entry via warrants. Enact Technologies, already a significant shareholder, increased its diluted stake by nearly 1 percentage point through the warrant tranche, signaling continued confidence in the company’s long-term valuation trajectory.

Hiliks Technologies announced on September 17, 2026, that its promoter, Extros Developers Private Limited, has executed a non-binding Letter of Intent (LOI) to sell a 4.65% equity stake in the company.

The proposed transaction involves the sale of 5,00,000 equity shares to a consortium comprising Enact Technologies Private Limited, Mr. Penumatsa Venkata Raju, and Mr. Venkata Lakshmi Narasimha Swamy Boyapati. The company confirmed that the proposed sellers and acquirers are not classified as related parties as of the date of the intimation.

Transaction Details

The deal is structured as a cash acquisition. The final price per share is yet to be determined and will be mutually negotiated after the completion of due diligence by the involved parties. The indicative timeline for closing the transaction remains undetermined pending these steps.

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transaction is subject to applicable laws, including the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, where relevant. No governmental or regulatory approvals beyond standard compliance requirements were explicitly detailed as pre-conditions in the filing, though the process remains subject to definitive document execution.